Synopsis: A global IT major bets big on India’s sovereign AI space with a $150 million investment, earning a bullish reiteration from an international brokerage with a 38% upside target.
India’s artificial intelligence ecosystem has been drawing serious capital, and one of the country’s largest technology exporters just made its most consequential bet yet on the homegrown AI future. The company’s stock surged nearly 3% after the investment was announced, reflecting the market’s optimism about what this deal could mean for its long-term positioning in an AI-driven world.
HCLTech Places $150 Million Bet on Sarvam AI
HCL Technologies has announced an investment of $150 million in Sarvam AI, an unlisted Indian AI company focused on building foundational models natively within the country. The deal gives HCLTech a 10.46% stake in the startup and values Sarvam AI at approximately $1.5 billion post-investment. The transaction is expected to close within the next few weeks.
According to Nomura, this marks the first time any Indian IT services company has made such a significant investment in a sovereign AI firm – a milestone the brokerage views as strategically important. Sarvam AI is not a generalist AI player. It develops models across language, speech, vision, and document processing, and its technology is already deployed across banking, insurance, government technology, and defence sectors.
The company’s conversational AI platform handles over 2 million interactions a day, while its Sarvam Vision product is being used to digitise millions of pages of records. Its speech models are processing large volumes of audio data every month, suggesting the platform is well past the early-stage phase.
Why Nomura Sees It as a Strong Value Unlock
Nomura has retained its Buy rating on HCLTech and maintained a target price of Rs 1,600 per share, implying an upside potential of close to 38% from current levels. The brokerage believes the investment could strengthen HCLTech’s positioning in emerging AI opportunities while helping it develop specialised solutions for clients across industries globally.
Specifically, Nomura points out that the funds will help Sarvam accelerate work in agentic AI, coding, and cybersecurity use cases. For HCLTech, the commercial opportunity lies in using Sarvam’s technology stack to build industry-specific and client-specific language models and AI solutions for its global enterprise clients.
The brokerage also highlights the multilingual angle – Sarvam AI’s language capabilities could be leveraged not just in India but also in international markets where localised AI is in demand.
The Sovereign AI Angle
One theme that runs through Nomura’s view is the growing global demand for sovereign AI – localised AI platforms that give governments and regulated industries greater control over data, compliance, and infrastructure. As more countries and enterprises look to reduce dependence on foreign AI models, homegrown alternatives like Sarvam are becoming strategically valuable.
HCLTech’s partnership could help accelerate the adoption of sovereign AI solutions for governments and large enterprises, the brokerage noted. The timing of the move is notable, coming at a moment when the Indian government itself is ramping up investments in domestic AI infrastructure.
HCLTech’s own FY26 results showed annualised Advanced AI revenues crossing $620 million, with the company flagging AI as its top priority heading into FY27. The investment in Sarvam fits squarely into that narrative.
HCL Technologies is a global IT services and software company headquartered in Noida. With a workforce of over 2.27 lakh employees across 60 countries, the company reported consolidated revenues of Rs 1,30,144 crore in FY26. It offers services spanning AI, digital, engineering, cloud, and enterprise software across major verticals.
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
